Document is current
Any future updates will be listed below
-
Authors
Zhang, Shuaipan
Zhu, Qingguang
Zhan, Chao
Cheng, Wei
Mingfang, Xiao
Fang, Min
Fang, Lei
-
Funding
Funding for this research was provided by:
Emergency scientific research project for prevention and control of new coronavirus (COVID-19) by Shanghai University of Traditional Chinese Medicine (No fund number)
Shanghai Further accelerate the three-year action plan for the development of Chinese medicine (ZY (2018-2020)-CCCX-2004-02)
National Key Clinical Difficult Diseases Clinical Collaborative Pilot Construction Project - Osteoarticular Degenerative Disease (ZY(2018-2020)-FWTX-2005)
High-level innovation team of Peak and Plateau Discipline in Traditional Chinese Medicine (30304114316)
- License Information
-
More Information
Article History
Received: 2 March 2020
Accepted: 16 August 2020
First Online: 27 August 2020
Ethics approval and consent to participate
: Ethical approval was requested and granted by the Ethics Committee of Huangshi Hospital of Traditional Chinese Medicine (item number: HSZYYJ-2020-003-01). All study participants will provide informed consent before starting any data collection by the clinical trial communicator. All participants will provide their written consent. Only the investigators will have access to the final data. This protocol was registered in the Chinese Clinical Trial Registry under identifier number ChiCTR2000029994 (18 February 2020).
: This section is “not applicable” as no personal information is provided in this manuscript.
: The authors declare that they have no competing interests.
